Keith Woods - 14 Jun 2024 Form 4/A - Amendment Insider Report for Neurogene Inc. (NGNE)

Source evidence Original filing metadata and source links for verification. 6 source fields
SEC form
4/A - Amendment
Accepted by SEC
16 Jun 2026, 17:32:05 UTC
Original report date
17 Jun 2024
Prior SEC filing
20 Jun 2024
Next SEC filing
29 Apr 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Donna M. Cochener, Attorney-in-Fact for Keith Woods

Key filing fact

Keith Woods filed Form 4/A - Amendment for Neurogene Inc. (NGNE) on 16 Jun 2026.

Key facts

  • This page summarizes Keith Woods's Form 4/A - Amendment filing for Neurogene Inc. (NGNE).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 16 Jun 2026, 17:32.

Change

  • Previous filing in this sequence was filed on 20 Jun 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0001996804 Primary reporting owner

Woods Keith

Relationship
Director
Address
C/O NEUROGENE INC., 535 W 24TH ST, 5TH FLOOR, NEW YORK
Signature
/s/ Donna M. Cochener, Attorney-in-Fact for Keith Woods
Signature date
16 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NGNE transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares
+7,700
Change %
Price
$0.000000*
Shares after
7,700
Date
14 Jun 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,700
Exercise price
$42.59
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This option is fully vested.

SEC remarks

This Form 4 was originally filed on June 17, 2024 using the incorrect CIK number for the Reporting Person and is being refiled under the correct CIK number. This filing amends and replaces the original filing in its entirety

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .